C4 Therapeutics Stock Forecast - Price Action Indicator
| CCCC Stock | USD 5.88 0.18 2.97% |
CCCC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast C4 Therapeutics stock prices and determine the direction of C4 Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of C4 Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
CCCC |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.03 | (0.19) |
| Check C4 Therapeutics Volatility | Backtest C4 Therapeutics | Information Ratio |
C4 Therapeutics Trading Date Momentum
| On November 11 2024 C4 Therapeutics was traded for 5.88 at the closing time. The top price for the day was 6.20 and the lowest listed price was 5.76 . The trading volume for the day was 827.3 K. The trading history from November 11, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.08% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare C4 Therapeutics to competition |
Other Forecasting Options for C4 Therapeutics
For every potential investor in CCCC, whether a beginner or expert, C4 Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CCCC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CCCC. Basic forecasting techniques help filter out the noise by identifying C4 Therapeutics' price trends.C4 Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with C4 Therapeutics stock to make a market-neutral strategy. Peer analysis of C4 Therapeutics could also be used in its relative valuation, which is a method of valuing C4 Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
C4 Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of C4 Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of C4 Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
C4 Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how C4 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading C4 Therapeutics shares will generate the highest return on investment. By undertsting and applying C4 Therapeutics stock market strength indicators, traders can identify C4 Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 58711.33 | |||
| Daily Balance Of Power | (0.41) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 5.98 | |||
| Day Typical Price | 5.95 | |||
| Price Action Indicator | (0.19) | |||
| Period Momentum Indicator | (0.18) |
C4 Therapeutics Risk Indicators
The analysis of C4 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in C4 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cccc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.68 | |||
| Semi Deviation | 3.55 | |||
| Standard Deviation | 4.89 | |||
| Variance | 23.9 | |||
| Downside Variance | 13.21 | |||
| Semi Variance | 12.63 | |||
| Expected Short fall | (5.10) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether C4 Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of C4 Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of C4 Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on C4 Therapeutics Stock:Check out Historical Fundamental Analysis of C4 Therapeutics to cross-verify your projections. For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of C4 Therapeutics. If investors know CCCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about C4 Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.71) | Revenue Per Share 0.522 | Quarterly Revenue Growth 0.387 | Return On Assets (0.21) | Return On Equity (0.46) |
The market value of C4 Therapeutics is measured differently than its book value, which is the value of CCCC that is recorded on the company's balance sheet. Investors also form their own opinion of C4 Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is C4 Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because C4 Therapeutics' market value can be influenced by many factors that don't directly affect C4 Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between C4 Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if C4 Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, C4 Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.